This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Published Erratum

. 2024 Jan;12(1):e1.

doi: 10.1016/S2213-8587(23)00360-1. Epub 2023 Nov 28.

Correction to Lancet Diabetes Endocrinol 2023; 11: 905-14

No authors listed

PMID: 38040017
PMCID: PMC10972760
DOI: 10.1016/S2213-8587(23)00360-1

Published Erratum

Correction to Lancet Diabetes Endocrinol 2023; 11: 905-14

No authors listed. Lancet Diabetes Endocrinol. 2024 Jan.

. 2024 Jan;12(1):e1.

doi: 10.1016/S2213-8587(23)00360-1. Epub 2023 Nov 28.

PMID: 38040017
PMCID: PMC10972760
DOI: 10.1016/S2213-8587(23)00360-1

No abstract available

PubMed Disclaimer

Erratum for

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
RECOVERY Collaborative Group. RECOVERY Collaborative Group. Lancet Diabetes Endocrinol. 2023 Dec;11(12):905-914. doi: 10.1016/S2213-8587(23)00253-X. Epub 2023 Oct 18. Lancet Diabetes Endocrinol. 2023. PMID: 37865101 Free PMC article. Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources